menu ☰
menu ˟

Switching to lumateperone improves weight gain, schizophrenia symptoms

12 Sep 2017
Intra-Cellular Therapies recently announced data that indicated improvements in weight gain and cardiometabolic, endocrine and schizophrenia outcomes after switching from standard antipsychotic care to lumateperone with no dose titration in individua...

Click here to view the full article which appeared in Psychiatry

IPH Logo